Español / German

EARLY DETECTION // PREVENTION // CURE

HOME

Prevention

Eight Steps to the Cure

Join QHM

Our History

ABC- You Decide

Yes Susan, Yes Susan

The Oral Link

Baby Tooth Root Canal

Chemo Fraud

Dangerous Mammograms

QHM Technology

Electromedicine

Anti-Cancer Herbals

Treatment Protocol

Tell-All Book

Food Matters

Crissy Knows

Videos

USA Clients

Your Trip to Ecuador

Beauty of Ecuador

 

 

 

 

 

 

 

 

 

 

 

A Research-Based

Two-Part Report on

CANCER CURED

October 1998 through December 2008

  Part I -- Unexpected Discovery of An Association between diseases

Part II -- Unique Therapeutic Approach in the Treatment of Cancer

 

This is a report of cases studied over a 10-year period involving subjects with cancer of varying types.  As a result of this study, an unexpected association between cancer and accompanying pathology was discovered and a unique approach to the treatment of cancer was developed and tested. 

In January 2006, there was enough conclusive evidence, from the methodology employed in this unique therapeutic approach, with medical procedures now FDA-cleared and covered by many insurance and Medicare, to indicate that all early breast cancers discovered by Quantum Health Management® (QHM®) technology can be considered curable  and  breast cancer can now be considered preventable.  Of course, time is the best indicator of the cure which is the obvious reason these subjects are continuously monitored long-term.  Many of the subjects studied before 2004 are no longer living due to the fact that the unexpected disease association link had not clearly materialized.

Background

Original research for this project began in 1979 in Peru in a study prompted by another study involving children with learning disabilities.  The Peru study was designed to look at diet as a factor in degeneration and cancer.  In 1979, the majority of Peruvians were eating the basic diet of their ancestors which included raw vegetables and, primarily, white meat fish caught daily in the cold waters off the coast of Peru.

As the economy of Peru began to improve, the diet began to gravitate towards more processed foods, colas and less fish and raw foods.  Our studies indicated an increase in doctor visits of the study group which was a probable indicator that diet could be an important factor in degeneration and cancer.  The factor discovered much later relating disease with jawbone/dental pathology was not considered in the earlier studies. 

In retrospect, it makes sense considering the fact that processed foods and colas generally have high sugar content and generally produce an acid environment in the biological terrain which can be a factor in dental/jawbone degeneration.  This is in direct contrast with primarily raw foods which help create an alkaline environment.

Our early studies on cancer involved primarily end-stage cancers.  At that time we did not know how to screen for early cancer involvement, thus, we received only subjects sent home to die.  As our technology progressed for the identification of factors that lead to the cancer process, the climate changed dramatically as we began to receive subjects with early stage cancers and thus  allowing us more opportunity for the development of methods for stopping the cancer. 

Development of The Quantum Health Management® (QHM®) Protocol

The QHM® protocol is a well-defined set of procedures utilized to correct the cancer process. Now that we know the primary cause of most, if not all, cancers (jawbone and dental-related issues), our long-term studies have allowed us to develop methodology that has had significant results in stopping most cancers.  The primary factors within the QHM® system are:

 

  • Early identification through QHM® technology
  • Radio or cryo ablation of tumor(s) when possible
  • Repair of jawbone necrosis or other related dental issues
  • Detoxification and regeneration of cellular health
  • Quarterly maintenance checks utilizing the QHM® health maintenance program

 The following cases cover a broad spectrum of stages and cancer types.  Many cases prior to the development of the QHM® approach, provided the background for its development. This report, therefore, will be divided into two parts: Part I – Subjects prior to QHM® development; Part II – Subjects treated with QHM® methodology. 

The following information is included in our studies but may not be included in the Part I and Part II samples on this page:

  • Conditions treated (Cancer  stages 1,2,3,4)   
  • Number of cases in each stage of disease
  • Treatment given (Doses, treatments, duration, number of days, etc.)
  • Results (Percent reduction of tumors, for example). 
  • Parameters used to measure efficacy
  • Percentage of patients where treatment worked or did not work
  • Study Population

Study Population

Random.  This study includes children and adults, male and female, ages 6-86 years of age from many geographical areas of North America.

 

Cases, Part 1

 

Part I cases involved subjects prior to the development of the QHM® protocol and prior to the recognition of oral pathology as a factor. Five out of a total of 20 early cases have been selected for this Part I report.

Case #P1011098NC

Female: Age 78

Approximate date of diagnosis: 7-98

Cancer:  Lung w/brain mets 

Stage: 4

Prognosis at time of entry:  Poor – 30 to 60 days

Tumor status: Numerous some >3cm

Primary Treatments prior to entry: CHEMO AND RADIATION

Results: tumor growth continued; subject lost ambulatory status and became bedridden.

Secondary Treatments given: Internal cleanse,  shark oil and herbal supplements.

Results:  Subject became ambulatory for 6 months until her death.  

Present status:  DECEASED

This was one of our earliest cases where only herbs and alternative methods were employed.  While the cancer was not arrested, her quality of life improved considerably until she expired.

 

Case #P1010600GA

Male: Age 6

Approximate date of diagnosis: 4-00

Cancer:  Inoperable brain tumor

Stage: 4

Prognosis at time of entry:  Poor – 3 months

Tumor status: 5cm

Primary Treatments prior to entry:  Radiation

Results:  No reduction in tumor size

Secondary Treatments:  Rife device, herbal, dietary changes

Results: In 30 days, CT scan indicated a 30% reduction in tumor size. Also, inflammation had minimized and steroids were no longer prescribed.  Subject lived 13 months longer than original prognosis.

Present status:  DECEASED

This was an important case in that it involved a child and that it began to alert us to the oral pathology issue that would later be confirmed.   This child 1 year earlier had been treated for an abscessed front tooth. At the time, we made no connection. While reviewing his records several years later, we found that the abscessed tooth was directly below the location of the brain tumor. We were seeing the child at the time the state of South Carolina raided our office.  The child was then removed from our program and sent to a treatment program in Houston, Texas where he died from an overdose of steroid drugs.

 

Case #P101153SC

Male: Age 5

Approximate date of diagnosis: 8-01

Cancer:  Inoperable liver tumor

Stage: 4

Prognosis at time of entry:  Poor –  60 days

Tumor status: Multiple with some >5cm

Primary Treatments prior to entry:  Chemotherapy

Results:  No reduction in tumor size

Secondary Treatments:  Rife device, herbal, dietary changes

Results: No indication of positive results other than improvement in quality of life.

Present status:  DECEASED

This was another pivotal case involving oral pathology which we later discovered, after reviewing his records, that this child had had a primary tooth pulpotomy performed in the lower right quadrant prior to his diagnosis of cancer.  Again, we did not make the dental connection at the time.

 

Case #P1091702SC

Female: Age 68

Approximate date of diagnosis: 6-02

Cancer:  Stomach cancer

Stage: 4

Prognosis at time of entry:  Poor – 90 days

Tumor status: 10cm

Primary Treatments prior to entry:  Chemo and Radiation

Results:  Non responsive to treatments

Secondary Treatments:  “A” protocol for 60 days

Results: Within 14 days subject was able to hold down soft food whereas, prior to program, she was unable to eat or drink without throwing up.  Subject began to have an increased level of energy.  Subject lived 5 months longer than original prognosis. Subject’s children removed her from the program due to the length of travel from her home to the research clinic.

Present status:  DECEASED

This case also demonstrated the relationship of oral pathology to her stomach cancer.  Later review of her records indicated that she had an infection in a front tooth socket which corresponded with the stomach meridian.

 

Case #P1010403SC

Female: Age 47

Approximate date of diagnosis: 6-02

Cancer:  Breast cancer w/mets to lung

Stage: 4

Prognosis at time of entry:  Poor – 3 days

Tumor status: Massive tumor in pleural cavity which collapsed the right lung

Primary Treatments prior to entry:  Breast mastectomy with tuck procedure followed the chemotherapy.

Results:  No tumor, no breast, but a chemo-induced tumor appeared unknowingly in pleural cavity.

Secondary Treatments:  Subject was hospitalized with collapsed lung and given a maximum of 3 days to live.  This was our first hospital case where the early beginning of QHM® technology was applied. 

Results:  Aggressive herbal treatments were administered in the hospital and subject responded in a dramatic manner.  Pleural tumor dissolved and flowed out of pleural shunt, the lung re-inflated on its own, and subject was able to leave the hospital in 15 days.

Oral pathology corrected:  NO

Present status:  DECEASED

While this was a dramatic recovery from a near-death experience, it demonstrated the power of aggressive alternative treatments before the QHM® system was fully developed.  It also demonstrates the possibilities for alternative treatments in cases where radio or cryo ablation may not be possible.  In this case, cryo ablation would have been an option had it been available at the time. Subject lived an additional 12 months from the original prognosis. In a later review of her records, subject had oral pathology (apparent cavitation) in the breast meridian.  Subject later died of physician error by her personal physician through the misapplication of drugs.

 

Cases, Part II

 

Part II cases involve subjects who participated or are continuously participating in QHM® technology.  We will demonstrate the importance of correcting oral pathology.  We will compare cases that had the oral pathology corrected vs. those cases where the pathology was not corrected, usually by refusal of the subject to have the surgery.

 

Non-corrected Oral Pathology Cases

(Sample of 5 out of 20 cases with similar results)

 

Case #P2020004SC

Female: Age 42

Approximate date of diagnosis: 2-04

Cancer:  Pancreatic

Stage: 4

Prognosis at time of entry:  Poor – 120 days

Tumor status:  Inoperable

Primary Treatments prior to entry: Chemotherapy

Results:  Non-responsive.  Subject was told by her oncologist there was nothing else that could be done.

Secondary Treatments:  Early QHM® technology was applied.  Oral surgery was planned to correct jaw pathology.  Liver ablation was set up to ablate a 2cm tumor.    

Results: Pancreatic mass disappeared in 60 days.  

Oral pathology corrected:  NO

Present status:  DECEASED  (medical error)

This was one of our first QHM® subjects.  Her dramatic defeat of pancreatic cancer gave her new hope, but unfortunately, she failed to carry through with the designed protocol.  She refused oral surgery and later died of liver cancer induced by the earlier chemotherapy  and an improperly performed medical procedure ordered by her personal physician.

 

Case #P2120104NC

Male: Age 86

Approximate date of diagnosis: 7-05

Cancer:  Lung, upper left lobe

Stage: 4

Prognosis at time of entry:  Poor – 90 days

Tumor status: 2cm 

Primary Treatments prior to entry: Chemotherapy and radiation

Results:  Non-responsive.  Subject was told by his oncologist there was nothing else that could be done.

Secondary Treatments:  QHM® technology was applied, including radio ablation. 

Results: Lung mass was successfully destroyed.  

Oral pathology corrected:  NO. Subject refused oral surgery

Present status:  DECEASED

This subject enjoyed more than 1 year of healthy living after a poor prognosis of only 3 months.  Subject was well on his way to complete recovery from lung cancer but he stated that he “hated to go to a dentist” which eventually caused his demise.  A tumor appeared on the same side as the lung tumor had been and began growing behind the eye.  This growth was essentially within the same meridian as the oral pathology which caused the lung mass.

 

Case #P2100604NC

Male: Age 82

Approximate date of diagnosis: 3-04

Cancer:  Liver

Stage: 4

Prognosis at time of entry:  Poor – 60 days

Tumor status: 5 tumors 2cm or slightly greater 

Primary Treatments prior to entry: None. Subject was told that there was nothing that could be done.

Primary QHM® %Treatments:  radio ablation, detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients. 

Results: Liver masses destroyed. 

Oral pathology corrected:  Subject did not complete all oral surgery due to financial problems.

Present status:  DECEASED

This subject lived an additional 3 years from his original prognosis of 60 days.  His  quality of life was excellent until his eventual death from new multiple tumors in the liver not previously picked up on scan.  He never was able to complete the necessary oral surgery due to financial limitations.

 

Case #P2080305CA

Female: Age 52

Approximate date of diagnosis: 11-04

Cancer:  Breast

Stage: 3

Prognosis at time of entry:  Fair

Tumor status: Inflammatory breast cancer 

Primary Treatments prior to entry: Chemotherapy for previous breast tumor in opposite breast.  Tumor was put into remission.  Ten years later, cancer reappeared in the opposite breast.

QHM® Treatments: Partial oral surgery performed,  detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients. 

Results: Inflammatory cancer put into remission 

Oral pathology corrected:  Subject did not complete all oral surgery due to financial problems.

Present status:  New breast tumor developed in same meridian as uncorrected oral pathology.

This subject has had reoccurring breast cancer due to not following protocol as directed.  The correction of oral pathology is expensive and, at times, must be repeated if a new infection occurs.  In this case, the subject had oral pathology corrected on the side of the first breast cancer that occurred over 20 years previously.  She failed to complete the oral surgery on the opposite side and it was this side where the inflammatory cancer developed and later, another tumor in the same breast which has now been ablated.  Subject agreed to complete the QHM® protocol and is presently in remission.

Present status:  Remission

 

Case #P2050305NC

Female: Age 43

Approximate date of diagnosis: 9-04

Cancer:  Breast

Stage: 1

Prognosis at time of entry:  Good

Tumor status: Early stage in situ 

Primary Treatments prior to entry: None

QHM® Treatments:   Detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients. 

Results: Cancer put into remission

Oral pathology corrected: NO.  Subject did not have oral surgery due to financial problems.

Present status:  New breast tumor in same breast.

This subject is another or our longer term cases.  While her original cancer was easily put into remission, her failure to complete the oral surgery resulted in a mass developing five years later.  She is presently undergoing a new QHM® treatment program and has agreed to follow protocol completely.

Present status:  Good

 

Corrected Oral Pathology Cases

(Sample of 5 out of 20 similar cases)

Case #P2050305SC

Female: Age 62

Approximate date of diagnosis: 9-01

Cancer:  Breast

Stage: 2

Prognosis at time of entry:  Good

Tumor status: 1cm (Invasive ductile carcinoma)

Primary Treatments prior to entry: None

QHM® Treatments:  Lumpectomy, detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients, Naltrexone 4.5mg 

Results: Cancer in remission

Oral pathology corrected:  Two years later after the lumpectomy.

Present status:  No evidence of cancer

This is our first breast cancer case treated with QHM® technology.  At the time of her entry into our program, we did not require the correction of oral pathology, nor  did we use radio or cryo ablation to destroy a mass (the technology was not available at that time).  Two years later, we asked her to have the oral pathology corrected and she complied (a cavitation in a former wisdom tooth site, same side as her former tumor site).  She has been eight years without cancer.  Her oncologist originally told her that if he had known she would not follow through with chemotherapy after the lumpectomy, he would have removed both her breasts while in surgery!  (South Carolina, where her lumpectomy was performed, is a non-medical rights state and allows the surgeon to make decisions that may be against the wishes of the patient.)

 

Case #P2131203MD

Female: Age 38

Approximate date of diagnosis: 9-03

Cancer:  Breast

Stage: 2

Prognosis at time of entry:  Fair

Tumor status: 5cm (Invasive ductile carcinoma)

Primary Treatments prior to entry: None

QHM® Treatments:  Radio ablation, detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients. 

Results: Cancer in remission

Oral pathology corrected:  Completed.

Present status:  No evidence of cancer

This subject was our first radio ablation case for breast cancer.  She is also the only case that developed complications.  This was due partially because of the size of the mass, but primarily from the failure to follow protocol and take antibiotics after the ablation.  The breast got infected, but with proper treatments, she recovered and is today cancer-free.

 

Case #5041721NC

Female: Age 32

Approximate date of diagnosis: 5-04

Cancer:  Breast

Stage: 1

Prognosis at time of entry:  Excellent

Tumor status: <1cm

Primary Treatments prior to entry: None

QHM® Treatments:  Radio ablation, detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients, Naltrexone 4.5mg 

Results: mass destroyed

Oral pathology corrected:  Completed.

Present status:  No evidence of cancer

This was our first subject to have her breast cancer  found through our QHM® screening center evaluation.  She had just had a mammogram which was negative.  She could not feel her mass and it was only visible with a breast MRI.

 

Case #5041721SC

Female: Age 52

Approximate date of diagnosis: 5-04

Cancer:  Lung w/mets to bone

Stage: 4

Prognosis at time of entry:  Poor

Tumor status: 2 cm upper left lobe

Primary Treatments prior to entry: Brain Surgery, chemo, radiation

Results: Brain tumor removed, lung tumor non-responsive

QHM® Treatments:  Radio ablation, detoxification, Ondamed treatments, supplementation developed by NCIT for cancer patients, Naltrexone 4.5mg 

Results: Lung mass destroyed, bone masses stopped growing

Oral pathology corrected:  Completed.

Present status:  No evidence of cancer

This subject has had a history of cancer over a 10-year period. She had had a brain tumor which was successfully removed 10 years prior to coming into our program.  Today she is cancer-free.

 

Case #2040000NC

Male: Age 73

Approximate date of diagnosis: 2-04

Original diagnosis:  Squamous cell Jaw cancer with met behind eye.

Stage: 4

Prognosis at time of entry:  Poor, terminal

Tumor status: Original tumor removed with surgery, new aggressive tumor appeared behind the eye after chemotherapy.

Primary Treatments prior to entry:  Surgery, chemo, radiation

Results: Surgical removal of jaw tumor successful.  Chemo-induced tumor behind the eye non-responsive to additional chemo.  Tumor was inoperative.

Original Protocol “C”   

Results: Tumor disappeared and verified.

Oral pathology corrected:  Completed.

Present status:  No evidence of cancer.  Continues QHM® maintenance program

This subject was a “terminal” case when he entered our program.  He was declared cancer-free in less than 10 months after his 90-day Protocol “C” treatment.  As of May 2009, subject is cancer-free and healthy following QHM® technology.

 

Evidence is conclusive from the NCIT studies, which samples above represent, that breast cancers and many other types of cancer are now curable.  To date, May 2009, 100% of the QHM® breast cancer cases are now cancer-free.  Other cases not mentioned in the sample above are cancer-free with some having been previously classified as terminal.  NCIT's goal is to have the cure for all cancers by the year 2010 after present studies are completed.

NCIT's studies, along with the genetic study listed on this website, indicate, without question, that oral pathology is the primary cause of all cancers.